What is the price target for KTRA stock?
6 analysts have analysed KTRA and the average price target is 14.28 USD. This implies a price increase of 6529.53% is expected in the next year compared to the current price of 0.2154.
KINTARA THERAPEUTICS INC (KTRA) Forecast, Price Target & Analyst Ratings
NASDAQ:KTRA • US49720K2006
Current stock price
0.2154 USD
-0.01 (-6.31%)
At close:
0.225 USD
+0.01 (+4.46%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KINTARA THERAPEUTICS INC (KTRA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$14.28
Upside
+ 6,529.53%
From current price of $0.22 to mean target of $14.28, Based on 6 analyst forecasts
Low
$14.14
Median
$14.28
High
$14.70
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for KTRA. The average price target is 14.28 USD. This implies a price increase of 6529.53% is expected in the next year compared to the current price of 0.2154.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
KTRA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about KTRA.
In the previous month the buy percentage consensus was at a similar level.
KTRA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-07-14 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-09-29 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-05-16 | Dawson James | Downgrade | Buy -> Neutral |
| 2022-01-20 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-30 | Aegis Capital | Maintains | Buy |
| 2021-09-28 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 11, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 183.36% | N/A 69.15% | N/A 70.02% | |||||||||||
| EBITDA YoY % growth | N/A | -6.2M | -8.3M -33.87% | -11.15M -34.34% | -8.38M 24.84% | -8.14M 2.86% | -37.64M -362.41% | -22.62M 39.90% | -14.74M 34.84% | -8.396M 43.04% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.72M | -6.21M -31.57% | -8.32M -33.98% | -11.17M -34.25% | -8.4M 24.80% | -8.15M 2.98% | -37.67M -362.21% | -22.68M 39.79% | -14.8M 34.74% | -8.451M 42.90% | N/A -136.11% | N/A -1.00% | N/A 37.57% | N/A 55.68% | N/A 196.73% | N/A 359.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -420.00 | -360.00 14.29% | -275.00 23.61% | N/A 46.96% | N/A 79.72% | -39.00 -31.85% | -25.50 34.62% | -9.49 62.78% | N/A 95.06% | N/A 17.39% | N/A 2.63% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
KINTARA THERAPEUTICS INC / KTRA Forecast FAQ
What is the next earnings date for KTRA stock?
KINTARA THERAPEUTICS INC (KTRA) will report earnings on 2024-11-11, after the market close.
How many analysts have analysed KINTARA THERAPEUTICS INC (KTRA)?
The number of analysts covering KINTARA THERAPEUTICS INC (KTRA) is 6.